HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
50 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CCND1
cyclin D1
Chromosome 11 · 11q13.3
NCBI Gene: 595Ensembl: ENSG00000110092.5HGNC: HGNC:1582UniProt: P24385
1,795PubMed Papers
21Diseases
2Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneOncogeneTranscription Factor
RESEARCH IMPACT
Highly StudiedTrending
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
positive regulation of G2/M transition of mitotic cell cyclemitotic G1 DNA damage checkpoint signalingprotein bindingcyclin-dependent protein kinase holoenzyme complexbreast cancerbreast carcinomabreast neoplasmprostate carcinoma
✦AI Summary

CCND1 encodes cyclin D1, a regulatory protein essential for cell cycle progression through the G1/S transition 123. Cyclin D1 functions as the regulatory component of the cyclin D1-CDK4 complex, which phosphorylates retinoblastoma (RB) protein family members, including RB1 14. This phosphorylation releases the transcription factor E2F from RB/E2F complexes, enabling transcription of E2F target genes that promote G1 phase progression 15. Cyclin D-CDK4 complexes integrate mitogenic and antimitogenic signals 3. Beyond cell cycle regulation, cyclin D1 exhibits transcriptional corepressor activity with INSM1 on NEUROD1 and INS promoters in a cell cycle-independent manner 6. Dysregulation of CCND1 is clinically significant in multiple malignancies. Mantle cell lymphoma is characterized by constitutive CCND1 overexpression through t(11;14)(CCND1;IGH) translocation 7. In gastric cancer, circNFATC3 enhances CCND1 mRNA stability through IGF2BP3 interaction, promoting cell proliferation 8. Multiple myeloma with t(11;14)(CCND1;IGH) shows venetoclax sensitivity, though resistance mechanisms involving RAS pathway mutations and genomic alterations emerge during treatment 9. Elevated CCND1 expression in chr11 hepatitis B-related liver fibrosis/cirrhosis correlates with immune infiltration patterns 10. The CCND1 c.870G>A polymorphism is associated with increased breast cancer risk in Caucasian populations 11 and brain tumor susceptibility, particularly gliomas 12.

Sources cited
1
CCND1 phosphorylates RB protein family members and regulates G1/S transition
PMID: 1827756
2
CCND1 phosphorylates RB and allows E2F dissociation for G1 phase progression
PMID: 1833066
3
CCND1-CDK4 complexes are major integrators of mitogenic/antimitogenic signals
PMID: 19412162
4
CCND1 hypophosphorylates RB1 in early G1 phase
PMID: 8114739
5
CCND1 regulates E2F-dependent transcription and mitogenic signal integration
PMID: 8302605
6
CCND1 exhibits transcriptional corepressor activity with INSM1
PMID: 16569215
7
Mantle cell lymphoma is characterized by constitutive CCND1 overexpression
PMID: 32861278
8
CircNFATC3 enhances CCND1 mRNA stability in gastric cancer through IGF2BP3
PMID: 37340423
9
Multiple myeloma with t(11;14)(CCND1;IGH) shows venetoclax sensitivity and resistance mechanisms
PMID: 41481388
10
CCND1 expression elevation associates with immune infiltration in hepatitis B-related cirrhosis
PMID: 40148411
11
CCND1 c.870G>A polymorphism associates with increased breast cancer risk
PMID: 28004353
12
CCND1 G870A polymorphism increases brain tumor risk, especially gliomas
PMID: 24870765
Disease Associationsⓘ21
breast cancerOpen Targets
0.66Moderate
breast carcinomaOpen Targets
0.61Moderate
breast neoplasmOpen Targets
0.57Moderate
prostate carcinomaOpen Targets
0.54Moderate
multiple myelomaOpen Targets
0.54Moderate
neurodegenerative diseaseOpen Targets
0.53Moderate
type 2 diabetes mellitusOpen Targets
0.52Moderate
AL amyloidosisOpen Targets
0.51Moderate
diabetes mellitusOpen Targets
0.49Moderate
neoplasmOpen Targets
0.46Moderate
endometrial cancerOpen Targets
0.44Moderate
von Hippel-Lindau diseaseOpen Targets
0.42Moderate
diabetic eye diseaseOpen Targets
0.41Moderate
diabetic retinopathyOpen Targets
0.41Moderate
Mantle cell lymphomaOpen Targets
0.41Moderate
head and neck squamous cell carcinomaOpen Targets
0.39Weak
cancerOpen Targets
0.38Weak
prostate cancerOpen Targets
0.38Weak
colorectal adenocarcinomaOpen Targets
0.38Weak
Endometrial Endometrioid AdenocarcinomaOpen Targets
0.37Weak
Multiple myelomaUniProt
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets2
BRICICLIBPhase I
G1/S-specific cyclin D1 inhibitor
PALBOCICLIBApproved
Cyclin-dependent kinase 4/cyclin D1 inhibitor
breast cancer
Related Genes
CDK2Protein interaction100%CDKN1BProtein interaction100%CDK6Protein interaction100%CDKN1AProtein interaction100%RB1Protein interaction100%CDK1Protein interaction100%
Tissue Expression6 tissues
Heart
100%
Liver
50%
Lung
26%
Brain
8%
Ovary
4%
Bone Marrow
3%
Gene Interaction Network
Click a node to explore
CCND1CDK2CDKN1BCDK6CDKN1ARB1CDK1
PROTEIN STRUCTURE
Preparing viewer…
PDB9CSK · 2.25 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.61LoF Tolerant
pLIⓘ
0.72Intermediate
Observed/Expected LoF0.36 [0.22–0.61]
RankingsWhere CCND1 stands among ~20K protein-coding genes
  • #65of 20,598
    Most Researched1,795 · top 1%
  • #711of 1,025
    FDA-Approved Drug Targets1
  • #4,217of 17,882
    Most Constrained (LOEUF)0.61 · top quartile
Genes detectedCCND1
Sources retrieved50 papers
Response time—
📄 Sources
50▼
1
Molecular Pathogenesis of Mantle Cell Lymphoma.
PMID: 32861278
Hematol Oncol Clin North Am · 2020
1.00
2
[Copy number variations of CCND1 gene and chromosome 11 centromere in acral melanoma].
PMID: 38825900
Zhonghua Bing Li Xue Za Zhi · 2024
0.90
3
CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability.
PMID: 37340423
J Transl Med · 2023
0.90
4
In leukemia, knock-down of the death inducer-obliterator gene would inhibit the proliferation of endothelial cells by inhibiting the expression of
PMID: 35178295
PeerJ · 2022
0.86
5
GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer.
PMID: 40145254
J Cell Mol Med · 2025
0.82